Home / Inspections / 1108061

FDA Inspection 1108061 — Central California Blood Center

Central California Blood Center — FEI 3002963670

The FDA completed an inspection of Central California Blood Center on October 18, 2019 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 18, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fresno, CA (United States)

Facility

Other inspections at this facility

  • 1319874 (NAI Fri Apr 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1049255 (NAI Fri Mar 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 967701 (NAI Mon Apr 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 856690 (NAI Mon Nov 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797705 (NAI Mon Sep 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources